| Summary: | The article provides an overview of the upcoming Annual Scientific Meeting of the American Headache Society, highlighting its structure, key topics, and new features. The meeting combines established scientific presentations, the latest research, and clinical education, with a keynote on open-label placebo by Dr. Ted Kaptchuk from Harvard University. New this year is a "Clinical Hot Topics" session focusing on side effects of headache treatments, added to complement basic science discussions. The program also includes plenaries on migraine symptomatology, biomarker research, and opportunities for networking and industry engagement.
|
|---|